The pharmacology of statins.
Sirtori CR.
Pharmacol Res. 2014 Oct;88:3-11. doi: 10.1016/j.phrs.2014.03.002. Epub 2014 Mar 20.
Clinical management of patients with drug-induced liver injury (DILI).
Björnsson ES.
United European Gastroenterol J. 2021 Sep;9(7):781-786. doi: 10.1002/ueg2.12113. Epub 2021 Jun 28.
Hepatotoxicity of statins and other lipid-lowering agents.
Björnsson ES.
Liver Int. 2017 Feb;37(2):173-178. doi: 10.1111/liv.13308. Epub 2016 Nov 27.
Traditional and novel non-statin lipid-lowering drugs.
Jain P.
Indian Heart J. 2024 Mar;76 Suppl 1(Suppl 1):S38-S43. doi: 10.1016/j.ihj.2023.11.003. Epub 2023 Nov 17.
Lipid-lowering agents and hepatotoxicity.
Demyen M, Alkhalloufi K, Pyrsopoulos NT.
Clin Liver Dis. 2013 Nov;17(4):699-714, x. doi: 10.1016/j.cld.2013.07.016.
Overcoming toxicity and side-effects of lipid-lowering therapies.
Wilkinson MJ, Laffin LJ, Davidson MH.
Best Pract Res Clin Endocrinol Metab. 2014 Jun;28(3):439-52. doi: 10.1016/j.beem.2014.01.006. Epub 2014 Jan 23.
Lipid-lowering agents that cause drug-induced hepatotoxicity.
Bhardwaj SS, Chalasani N.
Clin Liver Dis. 2007 Aug;11(3):597-613, vii. doi: 10.1016/j.cld.2007.06.010.
Toxin-induced hepatic injury.
Lopez AM, Hendrickson RG.
Emerg Med Clin North Am. 2014 Feb;32(1):103-25. doi: 10.1016/j.emc.2013.09.005.
Atorvastatin-induced Myositis and Drug-induced Liver Injury.
Kashyap K, Bisht K, Dhar M, Mittal K.
J Assoc Physicians India. 2023 Oct;71(10):96-98. doi: 10.59556/japi.71.0309.
Hepatotoxicity associated with statins.
Karahalil B, Hare E, Koç G, Uslu İ, Şentürk K, Özkan Y.
Arh Hig Rada Toksikol. 2017 Dec 20;68(4):254-260. doi: 10.1515/aiht-2017-68-2994.
